“Correction of Experimental Hypertensive Neuroretinopathy With Semax”. Journal of Pharmaceutical Negative Results 13, no. 3 (September 20, 2022): 41–45. Accessed June 5, 2026. https://pnrjournal.com/index.php/home/article/view/220.